import { Helmet } from 'react-helmet-async';
import { Link } from 'react-router-dom';
import BlogCTA from '@/components/BlogCTA';
import KeyStats from '@/components/KeyStats';

const AiRadiologyAccuracyByCareSetting = () => {
  const post = {
    title: 'AI Radiology Accuracy Varies by Care Setting',
    dateIso: '2026-09-16',
    date: 'September 16, 2026',
    category: 'Buyer Guide',
    readingTime: 7,
    description: 'A Neiman Health Policy Institute study found an aneurysm-detection AI algorithm excelled in inpatient and ED settings but underperformed in outpatient care.',
  };

  return (
    <>
      <Helmet defer={false}>
        <title>AI Radiology Accuracy Varies by Care Setting | xAID</title>
        <meta name="description" content={post.description} />
        <link rel="canonical" href="https://xaid.ai/blog/ai-radiology-accuracy-by-care-setting/" />
        <meta property="og:type" content="article" />
        <meta property="og:title" content="AI Radiology Accuracy Varies by Care Setting | xAID" />
        <meta property="og:description" content={post.description} />
        <meta property="og:image" content="https://xaid.ai/og-image.png" />
        <meta property="og:site_name" content="xAID" />
        <meta property="article:published_time" content={post.dateIso} />
        <meta name="twitter:card" content="summary_large_image" />
        <meta name="twitter:title" content="AI Radiology Accuracy Varies by Care Setting | xAID" />
        <meta name="twitter:description" content={post.description} />
        <meta name="twitter:image" content="https://xaid.ai/og-image.png" />
        <script type="application/ld+json">{JSON.stringify({
          "@context": "https://schema.org",
          "@type": "BreadcrumbList",
          "itemListElement": [
            { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://xaid.ai/" },
            { "@type": "ListItem", "position": 2, "name": "Blog", "item": "https://xaid.ai/blog" },
            { "@type": "ListItem", "position": 3, "name": post.title, "item": "https://xaid.ai/blog/ai-radiology-accuracy-by-care-setting" }
          ]
        })}</script>
        <script type="application/ld+json">{JSON.stringify({
          "@context": "https://schema.org",
          "@type": "BlogPosting",
          "headline": post.title,
          "description": post.description,
          "datePublished": post.dateIso,
          "dateModified": post.dateIso,
          "url": "https://xaid.ai/blog/ai-radiology-accuracy-by-care-setting",
          "image": "https://xaid.ai/og-image.png",
          "author": { "@type": "Organization", "name": "xAID", "url": "https://xaid.ai" },
          "publisher": { "@type": "Organization", "name": "xAID", "url": "https://xaid.ai" },
          "keywords": "ai radiology accuracy, ai radiology accuracy by setting, radiology ai vendor validation, ai radiology outpatient vs inpatient, radiology ai evaluation"
        })}</script>
        <script type="application/ld+json">{JSON.stringify({
          "@context": "https://schema.org",
          "@type": "FAQPage",
          "mainEntity": [
            {
              "@type": "Question",
              "name": "Does an AI radiology algorithm's published accuracy apply in every care setting?",
              "acceptedAnswer": {
                "@type": "Answer",
                "text": "Not necessarily. A 2026 study from the Harvey L. Neiman Health Policy Institute, published in the Journal of the American College of Radiology, found that a commercial, FDA-cleared intracranial-aneurysm detection algorithm performed strongly in inpatient and emergency-department settings but showed weaker, less favorable results in outpatient imaging within the same health system. A single aggregate sensitivity or specificity figure can mask large differences by deployment context."
              }
            },
            {
              "@type": "Question",
              "name": "What did the Neiman Health Policy Institute study find about AI and aneurysm detection?",
              "acceptedAnswer": {
                "@type": "Answer",
                "text": "Researchers ran the algorithm in shadow mode alongside radiologists on 3,856 CT angiography exams across Northwell Health. Overall, AI sensitivity was 84.6% versus 71.8% for radiologists, while AI's positive predictive value was 78.2% versus 92.7% for radiologists, and the two agreed in more than 96% of cases. AI added 55 true-positive aneurysms radiologists missed (a 39% relative increase) but also produced 46 false positives. In the inpatient setting AI added 18 true positives against 7 false positives; in outpatient care it added only 4 true positives and generated more false positives than true positives."
              }
            },
            {
              "@type": "Question",
              "name": "Why did the AI algorithm perform worse in outpatient imaging?",
              "acceptedAnswer": {
                "@type": "Answer",
                "text": "Study co-author Matthew Barish, MD, suggested that higher-acuity inpatient and emergency exams are clinically more complex, creating more opportunities for AI to catch findings radiologists might miss under time pressure. Outpatient studies tend to be lower-acuity and lower pretest-probability, so the same detection threshold that helps in acute settings produces comparatively more false alarms in outpatient volume."
              }
            },
            {
              "@type": "Question",
              "name": "What should outpatient imaging centers ask AI vendors for before buying?",
              "acceptedAnswer": {
                "@type": "Answer",
                "text": "Ask for performance data broken out by care setting and patient population, not just a single aggregate sensitivity/specificity pair. As Neiman Institute executive director Elizabeth Rula, PhD, put it, organizations should evaluate AI based on how it performs in real-world use, not solely on results from its original testing environment. Outpatient centers and community hospitals should request setting-specific validation, understand the local false-positive burden it implies for radiologist workflow, and treat vendor accuracy claims as context-dependent rather than portable."
              }
            }
          ]
        })}</script>
      </Helmet>

      <div className="min-h-screen bg-background text-foreground">

        {/* Header */}
        <section className="pt-32 md:pt-40 pb-10">
          <div className="container-xaid max-w-3xl mx-auto">
            <div className="flex flex-wrap items-center gap-3 mb-6">
              <Link to="/blog/" className="text-white/60 hover:text-white/60 text-[15px] font-light transition-colors">← Blog</Link>
              <span className="bg-xaid-blue/20 text-xaid-blue text-xs font-medium px-3 py-1 rounded-full">
                Buyer Guide
              </span>
              <span className="text-white/60 text-sm">{post.date}</span>
              <span className="text-white/60 text-sm">{`${post.readingTime} min read`}</span>
            </div>
            <h1 className="text-3xl md:text-4xl lg:text-5xl font-light text-white leading-[1.3] mb-6">
              AI radiology accuracy isn't one number.<br />
              <span className="text-white/60">It changes by care setting.</span>
            </h1>
            <p className="text-white/60 text-lg font-light leading-[1.65]">
              A new Neiman Health Policy Institute study of a commercial aneurysm-detection algorithm found strong results in inpatient and ED settings — and weaker ones in outpatient care, the exact setting where most community imaging happens. Here's what that means for how buyers should evaluate any AI vendor's accuracy claims.
            </p>
          </div>
        </section>

        {/* Key stats */}
        <KeyStats
          items={[
            { stat: '3,856', label: 'CT angiograms evaluated', sub: 'one health system, shadow mode' },
            { stat: '18 vs 4', label: 'True positives added by AI', sub: 'inpatient vs outpatient' },
            { stat: '84.6% vs 71.8%', label: 'Overall sensitivity', sub: 'AI vs radiologist alone' },
            { stat: '78.2% vs 92.7%', label: 'Overall PPV', sub: 'AI vs radiologist alone' },
          ]}
        />

        {/* Article body */}
        <article className="section-padding bg-[#EBEBEB]">
          <div className="container-xaid">
            <div className="bg-white rounded-2xl p-8 md:p-16 max-w-3xl mx-auto">

              <h2 className="text-[28px] font-normal leading-[1.15] text-[#0D0D0D] mb-4">
                What the study found
              </h2>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-4">
                Researchers from the <a href="https://www.neimanhpi.org/press-releases/ai-helps-radiologists-detect-39-more-brain-aneurysm-cases-in-real-world-study/" target="_blank" rel="noopener noreferrer" className="text-xaid-blue-strong underline underline-offset-2">Harvey L. Neiman Health Policy Institute</a>, working with radiologists at Northwell Health, ran a commercially available, FDA-cleared intracranial-aneurysm detection algorithm in "shadow mode" — processing exams in parallel without influencing patient care — across <strong>3,856</strong> CT angiography (CTA) studies in one large integrated health system. The results were published in the <em>Journal of the American College of Radiology</em>, as first covered by <a href="https://radiologybusiness.com/topics/artificial-intelligence/radiology-ai-excels-certain-real-world-healthcare-settings-more-so-others" target="_blank" rel="noopener noreferrer" className="text-xaid-blue-strong underline underline-offset-2">Radiology Business</a>.
              </p>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-4">
                On aggregate, the numbers look favorable: overall AI sensitivity was <a href="https://www.neimanhpi.org/press-releases/ai-helps-radiologists-detect-39-more-brain-aneurysm-cases-in-real-world-study/" target="_blank" rel="noopener noreferrer" className="text-xaid-blue-strong underline underline-offset-2"><strong>84.6%</strong> versus <strong>71.8%</strong></a> for radiologists reading alone, and the algorithm and radiologists agreed on more than <strong>96%</strong> of cases. AI flagged <strong>55</strong> true-positive aneurysms that radiologists had missed — a <strong>39%</strong> relative increase in detection — while also producing <strong>46</strong> false-positive alerts. Positive predictive value told a more mixed story: <strong>78.2%</strong> for AI versus <strong>92.7%</strong> for radiologists, meaning roughly one in five AI-flagged findings did not hold up as a true aneurysm.
              </p>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-8">
                That single aggregate, though, hid a sharp split by care setting. In the <strong>inpatient</strong> population, AI added <strong>18</strong> true-positive detections against just <strong>7</strong> false positives — a clearly favorable ratio. Performance in the <strong>emergency department</strong> was also described as favorable. In <strong>outpatient</strong> imaging, by contrast, AI added only <strong>4</strong> true positives and generated more false positives than true positives — the setting where the algorithm's real-world value was weakest.
              </p>

              <h2 className="text-[28px] font-normal leading-[1.15] text-[#0D0D0D] mb-4">
                Why performance dropped in outpatient care
              </h2>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-4">
                Study co-author Matthew Barish, MD, FACR, FSAR, offered a likely explanation: <a href="https://www.neimanhpi.org/press-releases/ai-helps-radiologists-detect-39-more-brain-aneurysm-cases-in-real-world-study/" target="_blank" rel="noopener noreferrer" className="text-xaid-blue-strong underline underline-offset-2">"...higher-acuity inpatient and emergency settings involve more clinically complex examinations, creating additional opportunities for AI to provide value by serving as a complementary detection tool alongside radiologist interpretation."</a> Lead author Shlomit Goldberg-Stein, MD, FACR, framed the overall pattern as complementary rather than one tool replacing the other: <a href="https://www.neimanhpi.org/press-releases/ai-helps-radiologists-detect-39-more-brain-aneurysm-cases-in-real-world-study/" target="_blank" rel="noopener noreferrer" className="text-xaid-blue-strong underline underline-offset-2">"the algorithm found additional true-positive aneurysms that enhanced overall detection performance, while radiologists identified important aneurysms that the algorithm missed. Together, they achieved better results than either could alone."</a>
              </p>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-8">
                Outpatient CTAs skew toward lower-acuity indications and lower pretest probability of a true aneurysm than inpatient or ED studies ordered for acute neurological symptoms. Run the same detection threshold against a lower-prevalence population and the false-positive rate rises relative to the true-positive yield — exactly the pattern the study observed. None of this means the algorithm is unreliable; it means its accuracy profile is not uniform across the settings where it gets deployed.
              </p>

              <h2 className="text-[28px] font-normal leading-[1.15] text-[#0D0D0D] mb-4">
                Inpatient/ED vs. outpatient: same algorithm, different results
              </h2>
              <div className="overflow-x-auto mb-8">
                <table className="w-full text-left border-collapse text-[14px]">
                  <thead>
                    <tr className="border-b border-gray-200">
                      <th className="py-3 pr-4 font-medium text-[#0D0D0D]">Care setting</th>
                      <th className="py-3 pr-4 font-medium text-[#0D0D0D]">True positives added by AI</th>
                      <th className="py-3 pr-4 font-medium text-[#0D0D0D]">False positives</th>
                      <th className="py-3 font-medium text-[#0D0D0D]">Overall read</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr className="border-b border-gray-100">
                      <td className="py-3 pr-4 text-[#444] font-light">Inpatient</td>
                      <td className="py-3 pr-4 text-[#444] font-light">18</td>
                      <td className="py-3 pr-4 text-[#444] font-light">7</td>
                      <td className="py-3 text-[#444] font-light">Favorable</td>
                    </tr>
                    <tr className="border-b border-gray-100">
                      <td className="py-3 pr-4 text-[#444] font-light">Emergency department</td>
                      <td className="py-3 pr-4 text-[#444] font-light">Not disclosed</td>
                      <td className="py-3 pr-4 text-[#444] font-light">Not disclosed</td>
                      <td className="py-3 text-[#444] font-light">Favorable</td>
                    </tr>
                    <tr>
                      <td className="py-3 pr-4 text-[#444] font-light">Outpatient</td>
                      <td className="py-3 pr-4 text-[#444] font-light">4</td>
                      <td className="py-3 pr-4 text-[#444] font-light">More than 4</td>
                      <td className="py-3 text-[#444] font-light">Weakest</td>
                    </tr>
                  </tbody>
                </table>
              </div>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-8">
                The <a href="https://www.neimanhpi.org/press-releases/ai-helps-radiologists-detect-39-more-brain-aneurysm-cases-in-real-world-study/" target="_blank" rel="noopener noreferrer" className="text-xaid-blue-strong underline underline-offset-2">source press release</a> did not disclose exact ED counts, only that ED performance was "also favorable" — a reminder that even published real-world studies don't always break out every setting with the same granularity buyers would want.
              </p>

              <h2 className="text-[28px] font-normal leading-[1.15] text-[#0D0D0D] mb-4">
                What this means for outpatient centers and community hospitals evaluating AI
              </h2>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-4">
                Neiman Institute executive director Elizabeth Rula, PhD, drew the buyer-facing conclusion directly: <a href="https://www.neimanhpi.org/press-releases/ai-helps-radiologists-detect-39-more-brain-aneurysm-cases-in-real-world-study/" target="_blank" rel="noopener noreferrer" className="text-xaid-blue-strong underline underline-offset-2">"the findings demonstrate why healthcare organizations should evaluate AI based on how it improves physician performance and patient care in real-world use, not solely on results achieved in its original testing environment."</a>
              </p>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-4">
                For outpatient imaging centers and community hospitals — the settings where this study's data was weakest, and where the bulk of routine imaging volume actually happens — the practical takeaway is a due-diligence checklist, not a reason to avoid AI:
              </p>
              <div className="space-y-4 mb-8">
                {[
                  {
                    title: 'Ask for setting-stratified validation, not one aggregate number',
                    desc: 'A single sensitivity/specificity pair can average away a real gap between how a tool performs on acute inpatient studies versus routine outpatient volume. Ask any vendor for performance broken out by care setting, patient acuity, and indication.',
                  },
                  {
                    title: 'Ask what population the validation set represents',
                    desc: "A model validated mostly on inpatient or ED cases may carry a different false-positive burden when it's pointed at a lower-prevalence outpatient population. Match the evidence to your own case mix before you trust the topline number.",
                  },
                  {
                    title: 'Weigh the false-positive workflow cost, not just the true-positive gain',
                    desc: 'More false positives than true positives in a given setting means more time radiologists spend adjudicating AI alerts that don\'t pan out — a real cost even when the tool never touches the final report.',
                  },
                ].map((item) => (
                  <div key={item.title} className="bg-gray-50 rounded-xl p-5">
                    <h3 className="text-[#0D0D0D] font-medium mb-2 text-base">{item.title}</h3>
                    <p className="text-[#666] text-[15px] leading-[1.65] font-light">{item.desc}</p>
                  </div>
                ))}
              </div>

              <h2 className="text-[28px] font-normal leading-[1.15] text-[#0D0D0D] mb-4">
                Where xAID fits
              </h2>
              <p className="text-[#444] text-[15px] leading-[1.65] font-light mb-8">
                This is exactly the evidence-led question xAID's model is built to survive: don't take a vendor's aggregate accuracy claim on faith, and don't rely on a single algorithm's isolated call either. Every xAID report is a comprehensive, structured draft that goes through in-house radiologist review before it reaches a client — ready-to-sign, with the reading radiologist's signature staying exactly where it belongs. Setting-specific validation data is something any serious AI radiology vendor, xAID included, should be able and willing to produce on request.
              </p>

              {/* FAQ */}
              <h2 className="text-[28px] font-normal leading-[1.15] text-[#0D0D0D] mb-6">Frequently asked questions</h2>
              <div className="space-y-6">
                {[
                  {
                    q: "Does an AI radiology algorithm's published accuracy apply in every care setting?",
                    a: "Not necessarily. A 2026 study from the Harvey L. Neiman Health Policy Institute, published in the Journal of the American College of Radiology, found that a commercial, FDA-cleared intracranial-aneurysm detection algorithm performed strongly in inpatient and emergency-department settings but showed weaker, less favorable results in outpatient imaging within the same health system. A single aggregate sensitivity or specificity figure can mask large differences by deployment context.",
                  },
                  {
                    q: 'What did the Neiman Health Policy Institute study find about AI and aneurysm detection?',
                    a: 'Researchers ran the algorithm in shadow mode alongside radiologists on 3,856 CT angiography exams across Northwell Health. Overall, AI sensitivity was 84.6% versus 71.8% for radiologists, while AI\'s positive predictive value was 78.2% versus 92.7% for radiologists, and the two agreed in more than 96% of cases. AI added 55 true-positive aneurysms radiologists missed (a 39% relative increase) but also produced 46 false positives. In the inpatient setting AI added 18 true positives against 7 false positives; in outpatient care it added only 4 true positives and generated more false positives than true positives.',
                  },
                  {
                    q: 'Why did the AI algorithm perform worse in outpatient imaging?',
                    a: 'Study co-author Matthew Barish, MD, suggested that higher-acuity inpatient and emergency exams are clinically more complex, creating more opportunities for AI to catch findings radiologists might miss under time pressure. Outpatient studies tend to be lower-acuity and lower pretest-probability, so the same detection threshold that helps in acute settings produces comparatively more false alarms in outpatient volume.',
                  },
                  {
                    q: 'What should outpatient imaging centers ask AI vendors for before buying?',
                    a: 'Ask for performance data broken out by care setting and patient population, not just a single aggregate sensitivity/specificity pair. As Neiman Institute executive director Elizabeth Rula, PhD, put it, organizations should evaluate AI based on how it performs in real-world use, not solely on results from its original testing environment. Outpatient centers and community hospitals should request setting-specific validation, understand the local false-positive burden it implies for radiologist workflow, and treat vendor accuracy claims as context-dependent rather than portable.',
                  },
                ].map((item) => (
                  <div key={item.q} className="border-b border-gray-100 pb-6">
                    <h3 className="text-[#0D0D0D] font-medium mb-2">{item.q}</h3>
                    <p className="text-[#666] text-[15px] leading-[1.65] font-light">{item.a}</p>
                  </div>
                ))}
              </div>

              <p className="text-[#757575] text-[13px] leading-[1.6] font-light mt-10">
                Source: Harvey L. Neiman Health Policy Institute, <a href="https://www.neimanhpi.org/press-releases/ai-helps-radiologists-detect-39-more-brain-aneurysm-cases-in-real-world-study/" target="_blank" rel="noopener noreferrer" className="text-[#666] underline hover:text-xaid-blue">"AI Helps Radiologists Detect 39% More Brain Aneurysm Cases in Real-World Study"</a> (2026), study published in the <em>Journal of the American College of Radiology</em>, as reported by <a href="https://radiologybusiness.com/topics/artificial-intelligence/radiology-ai-excels-certain-real-world-healthcare-settings-more-so-others" target="_blank" rel="noopener noreferrer" className="text-[#666] underline hover:text-xaid-blue">Radiology Business</a>. Figures are rounded as reported.
              </p>

            </div>
          </div>
        </article>

        <BlogCTA
          heading="Ask harder questions of any AI vendor's accuracy claims"
          sub="xAID's reports are structured, in-house radiologist-reviewed drafts, ready for your radiologist to sign. Try it on 5 free studies."
          primaryLabel="Request free pilot"
          primaryTo="/#contact-us"
          secondaryLabel="See how it works"
          secondaryTo="/how-ai-ct-reporting-works/"
        />

        {/* Related */}
        <section className="section-padding">
          <div className="container-xaid max-w-3xl mx-auto">
            <h2 className="text-xl font-normal text-white mb-6">Related</h2>
            <div className="grid grid-cols-1 md:grid-cols-3 gap-4">
              <Link to="/blog/how-accurate-is-ai-radiology-reporting/" className="bg-white/5 border border-white/10 rounded-xl p-5 hover:bg-white/10 transition-colors group">
                <div className="text-xaid-blue text-xs font-medium mb-2">Clinical Evidence</div>
                <div className="text-white text-sm font-medium group-hover:text-xaid-blue transition-colors leading-snug">How Accurate Is AI Radiology Reporting?</div>
              </Link>
              <Link to="/blog/radiology-ai-clinical-outcomes-evidence-gap/" className="bg-white/5 border border-white/10 rounded-xl p-5 hover:bg-white/10 transition-colors group">
                <div className="text-xaid-blue text-xs font-medium mb-2">Clinical Evidence</div>
                <div className="text-white text-sm font-medium group-hover:text-xaid-blue transition-colors leading-snug">Radiology AI and Clinical Outcomes: The Evidence Gap</div>
              </Link>
              <Link to="/blog/radiology-ai-vendor-evaluation-checklist/" className="bg-white/5 border border-white/10 rounded-xl p-5 hover:bg-white/10 transition-colors group">
                <div className="text-xaid-blue text-xs font-medium mb-2">Buyer Guide</div>
                <div className="text-white text-sm font-medium group-hover:text-xaid-blue transition-colors leading-snug">ECRI's AI Error Tracker and the Vendor Evaluation Checklist</div>
              </Link>
            </div>
          </div>
        </section>

      </div>
    </>
  );
};

export default AiRadiologyAccuracyByCareSetting;
